
Synergy Pharmasource Private Limited
About Synergy Pharmasource Private Limited
Data last updated:
Synergy Pharmasource Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2011PTC063969. Its GSTIN is 24AAPCS4382P1ZJ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjaykumar Jitendrabhai Jha and Nazneen Hamid.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.413 4th Floor Shanti Arcade Opp. Pushpak Apartment 132 Ft Ring Road Naranpura, Ahmedabad, Gujarat, India – 380013.
As per the financials filed for FY 2024, the company reported a revenue of ₹54.89 Lakh. For the same year it recorded a net loss of ₹17,000 (net margin -0.3%) and EBITDA of -₹17,000 (EBITDA margin -0.3%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.413 4th Floor Shanti Arcade Opp. Pushpak Apartment 132 Ft Ring Road Naranpura, Ahmedabad, Gujarat, India – 380013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Synergy Pharmasource is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Synergy Pharmasource Private Limited
FY 2025 filings availableSynergy Pharmasource Private Limited reported revenue of ₹54.89 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹17,000 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹17,000 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.3% | |
| Net Profit Margin | -0.3% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synergy Pharmasource are in the company report.
: available in the company report
Board of Directors of Synergy Pharmasource Private Limited
Synergy Pharmasource has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjaykumar Jitendrabhai Jha Also directs: Injexa Lifesciences Private Limited, Santis Pharmaceuticals Private Limited, Cuidado Medico Private Limited and 5 more | Director | 09 Feb 2011 | 15 Years 8 Months | Current |
| Nazneen Hamid | Director | 09 Feb 2011 | 15 Years 8 Months | Current |
| Hetal Kaushal Shah Also directs: Synerzys Lifecare Private Limited | Director | 09 Feb 2011 | 15 Years 8 Months | Current |
Peer Comparison
Synergy Pharmasource Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Qristol Healthcare Private Limited | ₹55.05 Lakh (FY 2023) | •••• | •••• | -53.0% | •••• | Dehradun, Uttarakhand, India |
| Ipsum Pharmaceuticals Private Limited | ₹55.01 Lakh (FY 2021) | •••• | •••• | -28.0% | •••• | Hyderabad, Telangana, India |
| Lift Life Pharmaceuticals Private Limited | ₹54.96 Lakh (FY 2023) | •••• | •••• | 1.0% | •••• | Chandigarh, India |
| Synergy Pharmasource Private Limited this company | ₹54.89 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Capchins (India) Private Limited | ₹54.81 Lakh (FY 2023) | •••• | •••• | -78.0% | •••• | Mumbai, Maharashtra, India |
Peers are the companies nearest to Synergy Pharmasource by revenue, above and below it, in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Synergy Pharmasource Private Limited is audited by ASHVIN K YAGNIK & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHVIN K YAGNIK & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Synergy Pharmasource Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Synergy Pharmasource.
: available in the company report
Recent Activity
Synergy Pharmasource Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Hetal Kaushal Shah was appointed as Director on 09 Feb 2011.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Synergy Pharmasource has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPCS4382P1ZJ | Gujarat | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Synergy Pharmasource is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 February 2011 (15+ years old) and is registered under CIN U24239GJ2011PTC063969.
Synergy Pharmasource has 3 current directors:
- Sanjaykumar Jitendrabhai Jha - Director
- Nazneen Hamid - Director
- Hetal Kaushal Shah - Director
The latest financial statements of Synergy Pharmasource on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Synergy Pharmasource is 24AAPCS4382P1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of Synergy Pharmasource is U24239GJ2011PTC063969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synergy Pharmasource was incorporated on 09 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Synergy Pharmasource by revenue are Qristol Healthcare Private Limited, Ipsum Pharmaceuticals Private Limited, Lift Life Pharmaceuticals Private Limited, Capchins (India) Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hetal Kaushal Shah was appointed as Director on 09 Feb 2011. Nazneen Hamid was appointed as Director on 09 Feb 2011. Sanjaykumar Jitendrabhai Jha was appointed as Director on 09 Feb 2011.
The registered office of Synergy Pharmasource is at Shop No.413 4th Floor Shanti Arcade Opp. Pushpak Apartment 132 Ft Ring Road Naranpura, Ahmedabad, Gujarat, India – 380013.
Synergy Pharmasource operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Synergy Pharmasource is compliant as of 13 July 2026. The company is actively filing with the Registrar of Companies.